Description
The U.S. Department of Veterans Affairs is seeking vendors who can provide Fresenius USA, Inc Monitors - Physio: Hemodialysis. The product must meet specific salient characteristics, including being FDA approved, having a touchscreen user interface, providing visual and audible alerts, and being compatible with other Hemodialysis Systems. The contract will be for a 12-month base period with four 12-month option periods. Vendors must demonstrate their ability to meet all requirements and provide uninterrupted supply of products on a national scale.
• The product must be FDA approved to non-invasively measure hematocrit, hemoglobin, oxygen saturation, and percent change in blood volume in real-time during hemodialysis treatment.
• The product must have a touchscreen user interface with continuous hematocrit, hemoglobin, oxygen saturation, and percent change in blood volume feedback displayed in graphical and trendline formats.
• The product must provide visual and audible alerts and/or messages for clinically relevant measurements per user-defined levels.
• The product must be capable of printing and storing basic patient monitoring sessions for up to 30 days.
• The product must support compatibility with other Hemodialysis Systems.
• The product must be mountable to common medical grade intravenous poles (pole mount).